Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck osteoporosis drug builds bone density in mid-stage trial
Reuters
Saturday, October 13, 2012 - 12:31pm
tags:
Merck, osteoporosis, Odanacatib
Should I Buy AstraZeneca?
Motley Fool
Saturday, October 13, 2012 - 12:30pm
tags:
AstraZeneca
Pharmas Across The Pond
Motley Fool
Saturday, October 13, 2012 - 12:30pm
tags:
AstraZeneca, GSK, Sanofi
Johnson & Johnson Third Quarter Earnings Sneak Peek
Wall St Cheat Street
Saturday, October 13, 2012 - 12:28pm
tags:
JNJ, earnings
Here’s Another Misstep for Pfizer to Explain
Wall St Cheat Street
Saturday, October 13, 2012 - 12:27pm
tags:
Pfizer
Does This FDA Approval Mean Anything?
Motley Fool
Saturday, October 13, 2012 - 12:26pm
tags:
Perrigo, smoking cessation
Lexicon Pushes On To Phase III
Seeking Alpha
Saturday, October 13, 2012 - 12:24pm
tags:
Lexicon Pharmaceuticals, LX1032, carcinoid syndrome
Another Prospective Alzheimer's Trial
Seeking Alpha
Saturday, October 13, 2012 - 12:23pm
tags:
solanezumab, Eli Lilly, LY2886721, gantenerumab, Roche
Skepticism On Eli Lilly's Alzheimer's Drug (video)
Forbes
Saturday, October 13, 2012 - 12:21pm
tags:
solanezumab, Eli Lilly
Affymetrix 3Q Guidance Disappoints
Yahoo/Zacks
Saturday, October 13, 2012 - 12:12pm
tags:
Affymetrix
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, October 13, 2012 - 12:07pm
tags:
Vivus, Affymax, NPS Pharmaceuticals
CEO Gaffe of the Week: Cell Therapeutics
Motley Fool
Saturday, October 13, 2012 - 12:05pm
tags:
Cell Therapeutics
Celgene gets Abraxane nod
Yahoo/Investor's Business Daily
Saturday, October 13, 2012 - 12:05pm
tags:
Celgene, Abraxane, lung cancer
NPS Pharma jumps ahead of Gattex FDA review
Yahoo/AP
Saturday, October 13, 2012 - 12:01pm
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Biogen IDEC Gets New Data, Pfizer Exec To Testify
Wall St Cheat Street
Saturday, October 13, 2012 - 11:59am
tags:
Biogen Idec, Pfizer
Healthcare Business Review: WellPoint’s Reorganization, AEterna Zentaris Crater
Wall St Cheat Street
Saturday, October 13, 2012 - 11:59am
tags:
Aeterna Zentaris
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, October 13, 2012 - 11:58am
tags:
Edwards Lifesciences, Threshold Pharmaceuticals, MannKind
Here are 5 Biopharmaceutical Companies on the Rise
Wall St Cheat Street
Saturday, October 13, 2012 - 11:55am
tags:
Pluristem, Ariad Pharmaceuticals, Sarepta Therapeutics, Amicus Therapeutics, StemCells
Vertex Gets Uneasy On Mixed Clinical Trial Results
Seeking Alpha
Friday, October 12, 2012 - 12:22pm
tags:
Vertex Pharmaceuticals, Kalydeco, cystic fibrosis
ArQule's Tivantinib Failure And Exelixis' Cabozantinib PDUFA: Is There A Correlation?
Seeking Alpha
Friday, October 12, 2012 - 12:17pm
tags:
Arqule, tivantinib, Exelixis, cabozantinib, non-small cell lung cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.